Glenmark Pharmaceuticals settles U.S. lawsuits for $7 million related to generic drugs, denying all allegations.

It was launched as Intron A by Schering-Plough (now Merck & Co) in the 1980s before being discontinued by the company in 2019 based on evaluation of its clinical activity and the emergence of ...

"Medicinal chemistry involves working in teams with scientists from a variety of other disciplines," says James Kaminski, a senior principal scientist at Schering Plough. "There is a lot of ...

As an example, both market share and sales of mometasone furoate (Nasonex; Schering–Plough) increased after the entry of generic fluticasone in the United States, according to the 2007 company ...

Prior treatments included topical and oral steroids, systemic antibiotics and antifungals, nystatin powder, A+D Ointment (Schering-Plough Kenilworth, NJ), and three different topical clotrimazole ...